510(k) K944063
K944063 is an FDA 510(k) premarket notification submitted by Sigma Diagnostics, Inc. for the device "FLUORESCENCE POLARIZATION IMMUNOASSAY CARBAMAZEPINE". The FDA issued a decision of Substantially Equivalent on Nov 10, 1994. The device falls under product code LGI (Fluorescence Polarization Immunoassay, Carbamazepine), a Class II device regulated under 21 CFR 862.3645. Sigma Diagnostics, Inc. has 163 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 10, 1994
- Date Received
- Aug 19, 1994
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Fluorescence Polarization Immunoassay, Carbamazepine
- Device Class
- Class II
- Regulation Number
- 862.3645
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Sigma Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.